Cancer letters
Journal
Overview
publication venue for
-
Integrating Machine Learning-Predicted Circulating Tumor Cells (CTCs) and circulating tumor DNA (ctDNA) in Metastatic Breast Cancer: a proof of principle study on endocrine resistance profiling.
2024
-
Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis..
604.
2024
-
Site-specific mutagenesis screening in KRASG12D mutant library to uncover resistance mechanisms to KRASG12D inhibitors..
591.
2024
-
A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation.
2024
-
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
2024
-
Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma.
2023
-
Acyl-CoA thioesterase 12 suppresses YAP-mediated hepatocarcinogenesis by limiting glycerolipid biosynthesis.
2023
-
Low-dose carbon monoxide suppresses metastatic progression of disseminated cancer cells.
2022
-
EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells..
521.
2021
-
Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development..
515.
2021
-
High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer..
514.
2021
-
Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes..
500.
2020
-
LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers..
486.
2020
-
Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment..
465.
2019
-
Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer..
448.
2019
-
Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression..
446.
2019
-
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces peripheral blood abnormalities and plasma cell neoplasms resembling multiple myeloma in mice..
440-441.
2018
-
Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysis..
430.
2018
-
Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c..
431.
2018
-
Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes..
423.
2018
-
Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomas..
414.
2017
-
African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression..
380.
2016
-
GSK-3 inhibition overcomes chemoresistance in human breast cancer..
380.
2016
-
Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM..
371.
2015
-
High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells..
368.
2015
-
Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models..
356.
2014
-
Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway..
355.
2014
-
Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer..
335.
2013
-
MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells..
331.
2012
-
Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent..
326.
2012
-
Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors..
325.
2012
-
Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models..
302.
2011
-
Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress..
282.
2009
-
NSC606985 induces apoptosis, exerts synergistic effects with cisplatin, and inhibits hypoxia-stabilized HIF-1alpha protein in human ovarian cancer cells..
278.
2009
-
S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor..
276.
2009
-
Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer..
276.
2008
-
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer..
270.
2008
-
c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases..
265.
2008
-
Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome..
248.
2006
-
P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions..
238.
2005
-
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation..
236.
2005
-
A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction..
233.
2005
-
Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen..
220.
2005
-
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas..
209.
2004
-
Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma..
193.
2003
-
Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9..
150.
2000
-
Phytohemagglutinin-L (PHA-L) lectin surface binding of N-linked beta 1-6 carbohydrate and its relationship to activated mutant ras in human pancreatic cancer cell lines..
107.
1996
-
Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine..
103.
1996
-
The potentiation of radiation response on murine tumor by fludarabine phosphate..
31.
1986
-
Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
2019
-
Imaging of human epidermal growth factor receptors for patient selection and response monitoring - From PET imaging and beyond.
2018
-
Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.
2017
-
Application of next-generation sequencing in gastrointestinal and liver tumors.
2016
-
Acute myelogenous leukemia stem cells: from Bench to Bedside.
2012
-
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.
2011
-
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects.
2005
-
Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer.
2022
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)